Mental Health

Mental Health Parity and Addiction Equity Act disallows insurers offering lower-quality benefits for behavioral health treatments.

Even after some pharmacy school classes resumed in-person, students had myriad barriers and motivators to attending because of the COVID-19 pandemic.

Nearly two-thirds of respondents had residual feelings of anxiety, depression, or PTSD after using prescription medications.

2021 was almost as difficult as 2020; learn ways to start the new year with these recommendations.

Study data showed that increased levels of infection, inflammation, and metabolic alterations frequently observed in people with depression and psychosis may be a cause rather than a consequence of these disorders.

New study results suggest that severe depression and sexual dysfunction, in particular, can affect a woman's attention, language, orientation, recall, registration, and visuospatial skills.

In a subset of 537 patients receiving the IV therapy across 178 clinics, there was a 54% response rate and 30% remission rate.

Incorporating mental distress screenings during cancer care have been historically difficult, despite the fact that these patients tend to be vulnerable to mental health challenges.

The agency previously granted a priority review for the supplemental new drug application and also approved the drug in 2015 to treat adults.

Ten quiz questions to assess your knowledge on common symptoms and treatments for schizophrenia.

There were no instances of participants withdrawing from the study due to an adverse event caused by psilocybin in the treatment of mental health conditions.

GeneSight Mental Health Monitor finds that many struggle to know the difference between teenage behavior and a mental health challenge.

Generalized anxiety disorder has symptoms that are similar to panic disorder, obsessive-compulsive disorder, and other types of anxiety.

The efficacy of aripiprazole could be mediated through a combination of partial agonist activity at D2 and 5-HT1A receptors and antagonist activity at 5-HT2A receptors.

Anxiety disorders and depression were cited by more than 80% of oncologists as the types of mental health distress seen most often for patients.

Ismail Lourido Ali, JD, director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses the problems with approaching public health issues, such as mental health and substance use disorders, with an industrialized approach to problem solving.

Ismail Lourido Ali, JD, director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses whether the adoption and acknowledgement of psychedelic medicine in health care systems looks likely for the future.

Factitious disorder is not the same as inventing medical problems for practical benefit, such as getting out of work or winning a lawsuit.

Ismail Lourido Ali, JD, director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses which environments each psychedelic medicine is likely to be administered.

Ismail Lourido Ali, JD, director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses which psychedelic drugs are currently under investigation for potential FDA approval.

Xanax is indicated for the acute treatment of generalized anxiety disorder and treatment of panic disorder with or without agoraphobia in adults.

David Olson, PhD, the chief innovation officer, head of scientific advisory board, and co-founder of delix therapeutics and an associate professor at University of California, Davis, discusses psychedelics and other psychoplastogens in the treatment of brain and mental health disorders.

Vraylar is an atypical antipsychotic indicated for the treatment of adult patients with schizophrenia and for manic, mixed, or depressive episodes for patients with bipolar I disorder.

Prevalence of type 2 diabetes has been found higher in people with bipolar disorder, schizophrenia, and major depression compared to the general population.

Universal school-based depression screening shows promise addressing mental health conditions in students.

Mean changes from baseline in weight, fasting glucose, total cholesterol, triglycerides, and low-density lipoprotein cholesterol were similar between lumateperone and placebo.

A panel of experts discuss the future of psychedelic medicine and the role of the pharmacy in that future.

Researchers to explore possible approaches for designing small molecule therapeutics to combat depression.

Study results show that those who completed CBT-AD sessions were more than 2.5 times more likely to achieve undetectable viral loads than those who underwent the usual care.

Individuals taking selective serotonin reuptake inhibitors, particularly fluoxetine (Prozac), were less likely to die of the virus than those in a matched control group, study results show.